Literature DB >> 12414793

Steroid responsiveness of renal epithelial cells. Dissociation of transrepression and transactivation.

Simone de Haij1, Ian M Adcock, Astrid C Bakker, Sam J P Gobin, Mohamed R Daha, Cees van Kooten.   

Abstract

Glucocorticoids modulate cellular and inflammatory responses via stimulation or inhibition of gene transcription. Inhibition of cytokine gene expression is mediated via repression of transcription factors, including NF-kappaB. Previously we have shown that cytokine production by renal epithelial cells is insensitive to the inhibitory action of dexamethasone. In this study we demonstrate that dexamethasone is unable to inhibit NF-kappaB activation in the renal epithelial cell line HK-2, as measured by IkappaB-alpha degradation and DNA binding activity. Transfection of an NF-kappaB-inducible reporter gene demonstrated that non-stimulated HK-2 cells contain a high level of constitutively active NF-kappaB compared with the steroid-sensitive airway epithelial cell line A549, which was not blocked by dexamethasone. Expression and nuclear translocation of the glucocorticoid receptor (GR) was comparable in both cell types. In HK-2 cells, dexamethasone stimulated expression of two glucocorticoid-responsive genes, beta(2)-adrenoreceptors and angiotensinogen. The capacity of GR to transactivate the native angiotensinogen glucocorticoid-responsive element (GRE) using chromatin-IP was not impaired. Moreover, dexamethasone activation of a GRE-driven reporter construct appeared to be equally effective, although less sensitive compared with A549 cells. In conclusion, we provide evidence that glucocorticoids are unable to repress the activity of NF-kappaB in renal epithelial cells in the presence of an intact stimulatory pathway.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12414793     DOI: 10.1074/jbc.M209836200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Contribution of a nuclear factor-kappaB binding site to human angiotensinogen promoter activity in renal proximal tubular cells.

Authors:  Omar W Acres; Ryousuke Satou; L Gabriel Navar; Hiroyuki Kobori
Journal:  Hypertension       Date:  2011-01-31       Impact factor: 10.190

2.  Dexamethasone induces connective tissue growth factor expression in renal tubular epithelial cells in a mouse strain-specific manner.

Authors:  Hirokazu Okada; Tomohiro Kikuta; Tsutomu Inoue; Yoshihiko Kanno; Shinichi Ban; Takeshi Sugaya; Masaharu Takigawa; Hiromichi Suzuki
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

3.  Guggulsterone enhances antitumor activity of gemcitabine in gallbladder cancer cells through suppression of NF-κB.

Authors:  Moon Hee Yang; Kyu Taek Lee; Sera Yang; Jong Kyoon Lee; Kwang Hyuck Lee; Il Hwan Moon; Jong Chul Rhee
Journal:  J Cancer Res Clin Oncol       Date:  2012-06-15       Impact factor: 4.553

4.  Farnesoid X receptor, overexpressed in pancreatic cancer with lymph node metastasis promotes cell migration and invasion.

Authors:  J Y Lee; K T Lee; J K Lee; K H Lee; K-T Jang; J S Heo; S H Choi; Yil Kim; J C Rhee
Journal:  Br J Cancer       Date:  2011-03-01       Impact factor: 7.640

5.  Costimulation with angiotensin II and interleukin 6 augments angiotensinogen expression in cultured human renal proximal tubular cells.

Authors:  Ryousuke Satou; Romer A Gonzalez-Villalobos; Kayoko Miyata; Naro Ohashi; Akemi Katsurada; L Gabriel Navar; Hiroyuki Kobori
Journal:  Am J Physiol Renal Physiol       Date:  2008-05-07

6.  IL-6 augments angiotensinogen in primary cultured renal proximal tubular cells.

Authors:  Ryousuke Satou; Romer A Gonzalez-Villalobos; Kayoko Miyata; Naro Ohashi; Maki Urushihara; Omar W Acres; L Gabriel Navar; Hiroyuki Kobori
Journal:  Mol Cell Endocrinol       Date:  2009-07-05       Impact factor: 4.102

7.  Dexamethasone ameliorates renal ischemia-reperfusion injury.

Authors:  Sanjeev Kumar; David A Allen; Julius E Kieswich; Nimesh S A Patel; Steven Harwood; Emanuela Mazzon; Salvatore Cuzzocrea; Martin J Raftery; Christoph Thiemermann; Muhammad M Yaqoob
Journal:  J Am Soc Nephrol       Date:  2009-09-24       Impact factor: 10.121

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.